Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
profiling with cutting-edge in vivo physiological phenotyping and pharmacological engineering. Through this comprehensive approach, we believe we are poised to make transformative breakthroughs in
-
the majority are international and the working language is English. The research group of Mikkel H. Schierup currently employs six postdocs and six PhD students in a variety of projects in evolutionary genomics
-
the majority are international and the working language is English. The research group of Mikkel H. Schierup currently employs six postdocs and six PhD students in a variety of projects in evolutionary genomics
-
functionality. We are seeking a candidate who can span the interface between animal nutrition and process technology and who is dedicated to the development of alternative, sustainable feed ingredients
-
, psychology, cognitive science, engineering, or related fields. Emphasis will be placed on the following: Research qualifications, which will be assessed in relation to the period of active research, the degree
-
possible thereafter. The successful candidate will be employed in the Ingredient and Dairy Technology section and will join the Food Proteins Research Group. Application Deadline: 30 May 2025 About the
-
of education and philosophy of technology). It has attracted a substantial amount of external funding in recent years and is strongly involved in interdisciplinary collaboration. The SDU Philosophy Section is
-
space through spatial ‘omics approaches. Responsibilities and qualifications The successful candidate should be eager to pursue ambitious research questions using latest-technology workflows and chart new
-
writing, scientific communication, and laboratory leadership. You will attend local and international scientific conferences. Your profile Applicants should hold a PhD in neurobiology or proteomics
-
project supported by the Challenge Programme of the Novo Nordisk Foundation: “Mathematical Modelling for Microbial Community Induced Metabolic Diseases”, led by Prof. Daniel Merkle. The expected starting